PPP3CB encodes one of three catalytic subunits (alpha, beta, gamma) of calcineurin (also called protein phosphatase 2B or PP2B), a calcium-dependent, calmodulin-stimulated serine/threonine phosphatase. Calcineurin is a heterodimer consisting of a catalytic subunit A (PPP3CA, PPP3CB, or PPP3CC) and a regulatory Ca2+-binding subunit B (PPP3R1 or PPP3R2).
Multi-level activation by Ca2+/calmodulin:
1. At low Ca2+, calcineurin A is bound to calcineurin B with only high-affinity Ca2+ sites occupied - inactive state PMID:26794871
2. Elevated Ca2+ occupies low-affinity sites on calcineurin B → conformational change → exposes calmodulin-binding domain → partial activation PMID:26794871
3. Ca2+/calmodulin binding displaces autoinhibitory domain (AID) from active site → full activation PMID:26794871
4. PPP3CB has a novel autoinhibitory segment (AIS, residues 416-423) in addition to AID (residues 474-496) PMID:26794871
PPP3CB has a unique proline-rich N-terminal sequence (poly-Pro domain) that determines substrate binding:
- CaN beta has the lowest Km values for all tested protein substrates PMID:19154138
- The poly-Pro domain is involved in substrate recognition PMID:19154138
- All CaN isoforms show same cytoplasmic distribution but differ in substrate specificities PMID:19154138
- Km for NFATC1: 0.69 μM; Km for DARPP32: 0.7 μM PMID:19154138
PPP3CB was identified as the key calcineurin isoform for TFEB regulation:
- Lysosomal Ca2+ release through MCOLN1 activates calcineurin PMID:25720963
- Calcineurin binds and dephosphorylates TFEB → nuclear translocation PMID:25720963
- siRNA specifically targeting PPP3CB suppressed starvation-induced nuclear translocation of TFEB PMID:25720963
- IRGM promotes calcineurin-TFEB association PMID:32753672
This study goes beyond the canonical MCOLN1/Ca2+ activation of calcineurin-TFEB (PMID:25720963) and reveals a new regulatory layer:
- Lysosomal damage recruits PPP3CB to damaged lysosomes via a Galectin-3 (LGALS3) → SMURF1 → PPP3CB/PPP3R1 scaffold PMID:37846590
- SMURF1 ubiquitinates PPP3CB at K146 with K63-linked chains, which displaces the autoinhibitory domain (AID) from the catalytic domain — a non-canonical activation mechanism independent of Ca2+/CaM alone
- K146R mutant reduces ubiquitination and weakens TFEB nuclear translocation
- PPP3CB AID directly interacts with TFEB residues 444-476
- This defines a spatial regulation model: lysosomal damage → local calcineurin activation → local TFEB dephosphorylation
Annotation implication: Supports lysosomal membrane localization (conditional) and positive regulation of autophagy annotations. Adds ubiquitin-dependent regulation as a new activation mechanism for PPP3CB.
Annotation implication: Primarily a cancer biology/clinical finding. The calcineurin→MEK→ERK axis is interesting but likely represents a downstream pleiotropic effect rather than a core function requiring new GO annotation.
Annotation implication: Adds PSD-95 as a specific substrate but cannot be attributed to PPP3CB specifically without isoform-resolution data.
Annotation implication: Biomarker association only — does not warrant GO annotation changes. Interesting for disease context but not functional annotation.
Annotation implication: Similar to PD — biomarker association, not a direct functional role.
Annotation implication: Reinforces existing annotations; no new functional insights specific to PPP3CB vs other calcineurin isoforms.
| Finding | Novel? | Impact on Annotations |
|---|---|---|
| SMURF1/K63-Ub activation at lysosomes | Yes — new activation mechanism | Supports lysosomal localization annotation; strengthens autophagy annotation |
| EGFR TKI resistance via MEK/ERK | Yes — new clinical context | Pleiotropic/clinical, not core function |
| PSD-95 Ser295 substrate | Yes — new specific substrate | Not PPP3CB-specific |
| PD/psychosis biomarker | Yes — new clinical association | No annotation impact |
| Ca2+/CaM activation, NFAT signaling | No — well established | Already annotated |
Session 2026-10-03 (completion pass, ADAPTIVE_IMMUNITY project). The falcon report
(PPP3CB-deep-research-falcon.md) was used as leads only; claims were traced to primary papers.
Adopted (verified in primary literature)
- CnA/CnB heterodimer, Ca2+/CaM-dependent Ser/Thr phosphatase, Fe/Zn catalytic centre
[PMID:26794871 "a heterodimer composed of a catalytic subunit A and an essential regulatory subunit B";
PMID:8524402 "the Zn/Fe-containing active site"].
- Lysosome-damage recruitment of a LGALS3-SMURF1-PPP3CB-PPP3R1 assembly, SMURF1 relief of AID
autoinhibition, PPP3CB AID binding TFEB 444-476 [PMID:37909662 "SMURF1 controlled the phosphatase
activity of the PPP3CB by promoting the dissociation of its autoinhibitory domain (AID) from its
catalytic domain (CD)."; "Additionally, it revealed that the AID domain of PPP3CB interacted with
444–476 amino acids of TFEB"]. Used as support for the TFEB core function and the NEW
positive regulation of autophagy row; lysosomal membrane localization was NOT added (conditional,
recruitment depends on anchoring proteins) and is raised as a suggested question.
Rejected / not used
- K63-linked ubiquitination of PPP3CB at K146 by SMURF1: not found in the cached full text of
PMID:37909662 (no "K146" or "K63" string); not adopted.
- "Ca2+/calmodulin displaces the AID": canonical model, but the CnA-beta structure reports that
calmodulin only reorients the AID PMID:26794871; description reworded accordingly.
- EGFR-TKI resistance via calcineurin/KSR2/MEK/ERK (Gazzeri 2024), Parkinson plasma proteomics and
psychosis blood-expression biomarkers: overexpression or association data, no GO consequence.
- PSD-95 S295 dephosphorylation: not isoform-resolved, not attributed to PPP3CB.
Report / notes errors
- The Xia et al. 2024 paper was cited in these notes as PMID:37846590; that PMID is an unrelated
editorial ("Antiplatelet treatment after PCI"). Correct PMID is 37909662 (resolved from
DOI 10.1080/15548627.2023.2267413 via Europe PMC).
- Report gives no PMIDs and nothing on TCR signaling specifically.
Other changes this pass
- 8 GO:0005515 rows (IRF2, mouse IRAK1, RCAN1 x3, SPATA33, PPP3R1, NHE1) -> REMOVE; earlier
MODIFY -> GO:0030346 proposals withdrawn (that term describes the partner binding calcineurin).
- GO:0070886 positive regulation of calcineurin-NFAT cascade (2 NAS) -> MODIFY to GO:0033173.
- GO:0005509 calcium ion binding (IDA, PMID:8524402) -> MARK_AS_OVER_ANNOTATED (Ca2+ sites are on CnB).
- T cell activation (TAS), protein dimerization, protein phosphatase 2B binding, hydrolase activity
-> KEEP_AS_NON_CORE.
- Core functions split into NFAT phosphatase (calcineurin-NFAT cascade) and TFEB phosphatase.